Crispr Infuses First Human in Landmark Gene-Editing Study

Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.

from NDTV Gadgets - Latest https://ift.tt/2XjoJ5n

Comments

Popular posts from this blog

Bitcoin, Ether Tumble After Fresh Case Engulfs Binance in Legal Trouble in US

Bitcoin, Ether Retain Profits Throughout Weekend, So Far April Seems Fruitful for Investors

iPhone 14, iPhone 14 Plus Yellow Variant Now Available for Pre-Booking With Discounts Upto Rs. 15,000